




Abstract Methods & Results
Protein arginine methyl transferases (PRMTs) are a
family of proteins that modify protein targets though
the addition of a methyl group (Figure 1). PRMTs play
roles in DNA repair, cancer, heart disease, epigenetic
programming, and many other cellular functions. The
biochemical mechanisms that govern PRMT
regulation are still poorly understood. Additionally,
arginine methylation appears to be a permanent
modification, as no arginine demethylases have been
identified. This implicates a further importance of
proper PRMT regulation. The Hevel lab has recently
characterized an intrinsic redox dependent modulator
of PRMT1 activity. We showed that cysteines 101 and
208 of PRMT1 sense redox conditions, which gives
rise to altered enzymatic activity. Interestingly, we
have also observed redox sensitivity in PRMT6, a
protein highly homologous to PRMT1. Comparisons of
oxidized and reduced PRMT6 crystal structures show
that cysteine residues (53 and 232) non-homologous
to those identified in PRMT1 form a disulfide bond, a
type of oxidized cysteine (Figure 2). This implies that
the mechanism of redox regulation in PRMT6 may be
different than in PRMT1. We hypothesize that one or
several of these cysteine residues are responsible for
the redox induced modulation of PRMT6 activity.
Is Redox Regulation of Protein Arginine Methyltransferase 6 Cysteine Mediated?
Figure 1: PRMT catalyzed reaction. target protein









Figure 2: Crystal structures of PRMT1 and PRMT6. Putative 
redox active cysteine residues are shown in red. A: PRMT1. 
B: Reduced PRMT6. C: Oxidized PRMT6.
A
Figure 4.  A western blot 
(anti-his) was utilized in 
order to determine potential 
problems with wild type 
expression. This experiment 
identified a relatively high 
concentration of protein 







Figure 3: Coomassie staine
of Δcys PRMT6 purification 
fractions. This procedure 
yields Δcys PRMT6 of 
adequate purity, however 
the wild type PRMT6 was 
not purified adequately 
using the same protocol. 
To test this hypothesis, we will 1) purify recombinant wild 
type and cysteineless PRMT6 proteins using Nickel affinity 
chromatography, and 2) measure the activity for these 
proteins under both oxidative and reductive conditions.  If 
our hypothesis is correct, the activity of cysteineless PRMT6 
will be unaffected by reductive/oxidative conditions.  
Continue to refine the PRMT6 expression protocol for 
high levels of soluble, active protein. Assay both wild 
type and cysteineless (mutant) forms of PRMT6 under 
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